JMIR Dermatology

JMIR Dermatology is the official journal of the International Society of Digital Health in Dermatology (ISDHD), formerly the International Society of Teledermatology (ISTD). 

Editor-in-Chief:

Robert Dellavalle, MD, PhD, MSPH, Professor and Head, Department of Dermatology, University of Minnesota Medical School


CiteScore 1.2

As an open-access journal, we are read by clinicians and patients alike and focus on applied science reporting the design and evaluation of health innovations and emerging technologies in dermatology. We publish original research, research letters, case reports, viewpoints, short articles, and reviews (both literature reviews and medical device/technology/app reviews). Articles are carefully copyedited and XML-tagged. JMIR Dermatology is the official journal of the International Society of Digital Health in Dermatology (ISDHD), formerly the International Society of Teledermatology (ISTD). 

JMIR Dermatology is indexed in PubMedPubMed Central (PMC), MEDLINE, Sherpa Romeo, ScopusDOAJ, and CABI. With a CiteScore of 1.2, JMIR Dermatology is a Q3 journal in the field of Dermatology, according to Scopus data.

Recent Articles

Article Thumbnail
Research Letter

September 01, 2023, marked the loss of iconic singer-songwriter Jimmy Buffett after a lengthy battle with lymphoma precipitating from Merkel cell carcinoma (MCC). Given Buffett’s prominent status, media coverage of his death was extensive.

|
Article Thumbnail
Research Letter

TikTok's social media platform can educate users about dermatology, but this longitudinal analysis of Skin of Color (SoC)-related TikTok hashtags from 2021 to 2022 suggests that non-dermatologist influencers continue to dominate content creation, highlighting the need for more participation from board-certified dermatologists to actively counter misinformation and address potential disparities in SoC healthcare.

|
Article Thumbnail
Reviews in Dermatology

Teledermoscopy has demonstrated benefits such as decreased costs and enhanced access to dermatology care for skin cancer detection. However, the heterogeneity among teledermoscopy studies hinders the systematic reviews’ synopsis of diagnostic outcomes, impeding trust and adoption in general practice and limiting overall health care benefits.

|
Article Thumbnail
Recruitment for Dermatology Trials/Studies

Limited data exist on the motivations and expectations of participants when enrolling in dermatology clinical trials, including melanoma early detection trials. Understanding participant motivators for research engagement has been identified as a prioritized area for trial methodology research.

|
Article Thumbnail
Theme Issue (2024): Diversity in Dermatology

Analyses of women dermatology literature authorship from 2018 to 2022 reveal a slight increase in total female authors, female first authors, and female senior authors with no substantial immediate impact of COVID-19 on current trends, encouraging future examination of long-term effects and ongoing promotion of systemic initiatives to support gender equity.

|
Article Thumbnail
Theme Issue (2024): Diversity in Dermatology

Analyses of women dermatology literature authorship from 2018 to 2022 reveal a slight increase in total female authors, female first authors, and female senior authors with no substantial immediate impact of COVID-19 on current trends, encouraging future examination of long-term effects and ongoing promotion of systemic initiatives to support gender equity.

|
Article Thumbnail
Theme Issue (2023): World Skin Health Day (Guinea)

Artificial intelligence (AI) has many applications in numerous medical fields, including dermatology. Although the majority of AI studies in dermatology focus on skin cancer, there is growing interest in the applicability of AI models in inflammatory diseases, such as psoriasis. Psoriatic disease is a chronic, inflammatory, immune-mediated systemic condition with multiple comorbidities and a significant impact on patients’ quality of life. Advanced treatments, including biologics and small molecules, have transformed the management of psoriatic disease. Nevertheless, there are still considerable unmet needs. Globally, delays in the diagnosis of the disease and its severity are common due to poor access to health care systems. Moreover, despite the abundance of treatments, we are unable to predict which is the right medication for the right patient, especially in resource-limited settings. AI could be an additional tool to address those needs. In this way, we can improve rates of diagnosis, accurately assess severity, and predict outcomes of treatment.

|
Article Thumbnail
Editorial

In 2023, JMIR Dermatology embraced papers treating all topics related to diseases of the skin, hair, and nails. This editorial aims to bring attention and recognize reviewers, staff, and authors for their contributions to the journal. JMIR Dermatology updated the Research Letter format and introduced the In Memorium article type to feature and celebrate highly accomplished and internationally recognized leaders in dermatology. We also summarize the 3 JMIR Dermatology publications from 2023 with the highest Altmetric scores and share what we look forward to in the coming year.

|
Article Thumbnail
E-Dermatology

Although several digital health interventions (DHIs) have shown promise in the care of skin diseases their uptake in Germany has been limited. To fully understand the reasons for the low uptake, an in-depth analysis of patients’ and health care providers’ barriers and facilitators in dermatology is needed.

|
Article Thumbnail
Case Report

Epithelioid hemangioendothelioma (EHE) is a rare vascular tumor with metastatic potential. EHE can have single- or multiorgan involvement, with presentations ranging from asymptomatic disease to pain and systemic symptoms. The extremely heterogeneous clinical presentation and disease progression complicates EHE diagnosis and management. We present the case of a 24-year-old woman with two periauricular erythematous papules, leading to the discovery of metastatic EHE through routine biopsy, despite a noncontributory medical history. Histology revealed the dermal proliferation of epithelioid cells and vacuoles containing red blood cells. Immunohistochemistry markers consistent with EHE solidified the diagnosis. Although extremely rare, prompt diagnosis of EHE is essential for informed decision-making and favorable outcomes. Key clinical and histopathological findings are highlighted to aid dermatologists in diagnosing and managing this uncommon condition.

|

We are working in partnership with